Preclinical tests for salicylhydrazones derivatives to explore their potential for new antituberculosis agents.
Ieque AL, Palomo CT, Gabriela de Freitas Spanhol V, Fróes da Motta Dacome ML, Júnior do Carmo Pereira J, Candido FC, Caleffi-Ferracioli KR, Dias Siqueira VL, Cardoso RF, Vandresen F, Alves-Olher VG, de Lima Scodro RB.
Ieque AL, et al. Among authors: candido fc.
Tuberculosis (Edinb). 2024 Sep;148:102545. doi: 10.1016/j.tube.2024.102545. Epub 2024 Jul 16.
Tuberculosis (Edinb). 2024.
PMID: 39079220